- Funding period:
-
01.10.2019 - 31.09.2023
- Project description:
-
The overall research objective of SECRET is to drive the understanding of the mutual regulation of the secretory pathway and signaling in breast and colorectal cancer, which will serve as a platform to identify and interrogate novel diagnostic and therapeutic strategies.
Partners
1. UNIVERSITETET I OSLO, PROBLEMVEIEN 5-7, 0313, OSLO, NO
2. UNIVERSITAETSKLINIKUM FREIBURG, HUGSTETTER STRASSE 49, 79106, FREIBURG, DE
3. CONSIGLIO NAZIONALE DELLE RICERCHE, PIAZZALE ALDO MORO 7, 00185, ROMA, IT
4. STICHTING VUMC, DE BOELELAAN 1117, 1081 HV, AMSTERDAM, NL
5. MEDIZINISCHE UNIVERSITAET WIEN, SPITALGASSE 23, 1090, WIEN, AT
6. OSLO UNIVERSITETSSYKEHUS HF, KIRKEVEIEN 166 TARNBYGGET, 0450, OSLO, NO
7. TEL AVIV UNIVERSITY, registration number IL589931187, RAMAT AVIV, 69978, TEL AVIV, IL
8. ANAXOMICS BIOTECH, S.L., CALLE BALMES (PISO 4 - PTA 2A) 89, 08008, Barcelona, ES
9. CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY GMBH, AM FLUGHAFEN 12-14, 79108, FREIBURG, DE
10. PROTATOUANS - ETAIREIA EREYNAS VIOTECHNOLOGIAS MONOPROSOPI ETAIREIA PERIORISMENIS EYTHINIS, ODOS NAVARCHOU VOTSI 3, 16675, GLYFADA, EL